Pharma Companies Pharma R&D Small Molecule Trials 
DrugBaron
JANUARY 31, 2024
Billions of dollars have been invested in companies promising to “revolutionise pharma R&D” through the application of artificial intelligence – but it is now clear that global pharma companies, and not just tech bro’s, are buying into the claims.
Drug Discovery World
AUGUST 7, 2024
Pharma R&D has been heading in the wrong direction, becoming progressively less efficient over the last few decades. Advancements in AI also have the potential to address key challenges in clinical trials. Take as an example patient recruitment, the most time-consuming part of a trial.
Expert insights. Personalized for you.
165 
Let's personalize your content